PREM Premier Air Charter Holdings Inc.
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1570937 · Fiscal year ends 12/31
Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY60.1%
TTM net income YoY-29.4%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin11.4%
Operating margin-7.8%
Net margin-11.4%
FCF margin-3.5%
EBITDA margin-4.6%
Returns
ROE-26,025.5%
ROA-11.4%
ROIC (approx.)-55.6%
Asset turnover0.99x
Leverage & solvency
Liabilities / assets92.7%
Debt / equity1.37x
Current ratio0.24x
Interest coverage-1.73x
Cash quality & payout
Operating cash flow / net income-0.28x
Accruals ratio-14.5%
Payout ratio—
Capex / revenue6.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $31.88M | $20.75M |
| Cost of revenue | $28.49M | $18.36M |
| Gross profit | $3.39M | $2.39M |
| SG&A expense | $4.38M | $1.99M |
| Operating income | -$2.70M | -$1.15M |
| Interest expense | $1.36M | $854,207 |
| Income tax | $0 | $0 |
| Net income | -$3.87M | -$2.19M |
| EBITDA | -$1.95M | -$930,091 |
| EPS (basic) | -0.01 | -0.01 |
| EPS (diluted) | -0.01 | -0.01 |
| Weighted avg. shares (diluted) | 272.30M | 237.87M |
| Balance sheet | ||
| Cash & equivalents | $213,175 | $225,228 |
| Receivables | $2.90M | $352,944 |
| Current assets | $3.73M | $997,117 |
| PP&E, net | $8.41M | $6.44M |
| Total assets | $36.05M | $27.75M |
| Current liabilities | $16.33M | $5.36M |
| Short-term debt | $4.04M | $166,410 |
| Long-term debt | $0 | $3.67M |
| Total debt | $4.04M | $3.84M |
| Total liabilities | $32.08M | $29.31M |
| Shareholders' equity | $3.97M | -$1.56M |
| Net debt | $3.82M | $3.61M |
| Shares outstanding | 280.85M | 237.87M |
| Cash flow statement | ||
| Operating cash flow | $1.15M | $3.09M |
| Capital expenditure | $2.55M | $1.49M |
| Free cash flow | -$1.40M | $1.60M |
| Investing cash flow | -$2.82M | -$928,554 |
| Financing cash flow | $1.65M | -$2.07M |
| Depreciation & amortization | $744,557 | $221,259 |
| Stock-based compensation | $42,500 | $0 |
Free plan shows the latest 2 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.